Syndax Pharmaceuticals, Inc. (SNDX) Financials

SNDX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 612.9 million 58.7 million
2023-09-30 399.2 million 40.0 million
2023-06-30 431.3 million 31.3 million
2023-03-31 459.8 million 24.3 million

SNDX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -41.3 million 8.3 million
2023-09-30 -44.7 million 8.3 million
2023-06-30 -35.4 million 8.1 million
2023-03-31 -39.2 million 6.2 million

SNDX Net Income

No data available :(

SNDX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 577.6 million - 1.6 million
2023-09-30 373.8 million - 1.9 million
2023-06-30 406.0 million - 2.1 million
2023-03-31 449.0 million - 1.1 million

SNDX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 72.5 million
2023-09-30 69.9 million
2023-06-30 69.6 million
2023-03-31 69.4 million

SNDX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 55.1 million 44.1 million 21.4 million
2023-09-30 - 39.1 million 17.3 million -
2023-06-30 - 34.8 million 14.9 million -
2023-03-31 - 34.1 million 12.0 million -

SNDX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 536000 268000
2023-09-30 - 3000
2023-06-30 - 152000
2023-03-31 - 113000

SNDX

Price: $22.60

52 week price:
11.22
25.34

Earnings Per Share: -2.98 USD

P/E Ratio: -8.53

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 44479

Ebitda: -15.3 million

Market Capitalization: 1.9 billion

Links: